These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 36384532)

  • 1. Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories.
    Abrams S; Wambua J; Santermans E; Willem L; Kuylen E; Coletti P; Libin P; Faes C; Petrof O; Herzog SA; Beutels P; Hens N
    Epidemics; 2021 Jun; 35():100449. PubMed ID: 33799289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plausibility of a third wave of COVID-19 in India: A mathematical modelling based analysis.
    Mandal S; Arinaminpathy N; Bhargava B; Panda S
    Indian J Med Res; 2021 May&Jun; 153(5&6):522-532. PubMed ID: 34643562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantial impact of post-vaccination contacts on cumulative infections during viral epidemics.
    Rochman N; Wolf Y; V Koonin E
    F1000Res; 2021; 10():315. PubMed ID: 34504684
    [No Abstract]   [Full Text] [Related]  

  • 4. Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19.
    Ayoub HH; Chemaitelly H; Seedat S; Makhoul M; Al Kanaani Z; Al Khal A; Al Kuwari E; Butt AA; Coyle P; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Rahim HA; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Bertollini R; Abu Raddad LJ
    J Glob Health; 2021 Jan; 11():05005. PubMed ID: 33643638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the Influence of Imbalanced Social Contact Matrices in Epidemic Models.
    Hamilton MA; Knight J; Mishra S
    Am J Epidemiol; 2024 Feb; 193(2):339-347. PubMed ID: 37715459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the number of severe COVID-19 cases and COVID-19-related deaths averted by a nationwide vaccination campaign in Republic of Korea.
    Hwang JH; Lee JH; Jang EJ; Kim RK; Lee KH; Park SK; Lee SE; Chae C; Lee S; Park YJ
    Osong Public Health Res Perspect; 2023 Jun; 14(3):164-172. PubMed ID: 37415433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRS epidemics with individual heterogeneity of immunity waning.
    El Khalifi M; Britton T
    J Theor Biol; 2024 Jun; 587():111815. PubMed ID: 38614211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Projecting COVID-19 intensive care admissions for policy advice, the Netherlands, February 2020 to January 2021.
    Klinkenberg D; Backer J; de Keizer N; Wallinga J
    Euro Surveill; 2024 Mar; 29(10):. PubMed ID: 38456214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterising information gains and losses when collecting multiple epidemic model outputs.
    Sherratt K; Srivastava A; Ainslie K; Singh DE; Cublier A; Marinescu MC; Carretero J; Garcia AC; Franco N; Willem L; Abrams S; Faes C; Beutels P; Hens N; Müller S; Charlton B; Ewert R; Paltra S; Rakow C; Rehmann J; Conrad T; Schütte C; Nagel K; Abbott S; Grah R; Niehus R; Prasse B; Sandmann F; Funk S
    Epidemics; 2024 Jun; 47():100765. PubMed ID: 38643546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national risk analysis model (NRAM) for the assessment of COVID-19 epidemic.
    Deng Q; Xiao X; Zhu L; Cao X; Liu K; Zhang H; Huang L; Yu F; Jiang H; Liu Y
    Risk Anal; 2023 Oct; 43(10):1946-1961. PubMed ID: 36617495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantial Impact of Post Vaccination Contacts on Cumulative Infections during Viral Epidemics.
    Rochman ND; Wolf YI; Koonin EV
    medRxiv; 2020 Dec; ():. PubMed ID: 33398300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: Development of a robust mathematical model and simulation package with consideration for ageing population and time delay for control action and resusceptibility.
    Ng KY; Gui MM
    Physica D; 2020 Oct; 411():132599. PubMed ID: 32536738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health impact of the U.S. Scenario Modeling Hub.
    Borchering RK; Healy JM; Cadwell BL; Johansson MA; Slayton RB; Wallace M; Biggerstaff M
    Epidemics; 2023 Sep; 44():100705. PubMed ID: 37579585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reopening California : Seeking Robust, Non-Dominated COVID-19 Exit Strategies.
    de Lima PN; Lempert R; Vardavas R; Baker L; Ringel J; Rutter CM; Ozik J; Collier N
    medRxiv; 2021 Apr; ():. PubMed ID: 33948599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How epidemics end.
    Charters E; Heitman K
    Centaurus; 2021 Feb; 63(1):210-224. PubMed ID: 33821019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial. COVID-19 outbreak and its countermeasures in the Republic of Korea.
    Kim KH; Choi EH; Kim SK
    J Neurosurg; 2020 Apr; 133(1):29-30. PubMed ID: 32302997
    [No Abstract]   [Full Text] [Related]  

  • 17. Model-informed COVID-19 exit strategy with projections of SARS-CoV-2 infections generated by variants in the Republic of Korea.
    Jung SM; Huh K; Radnaabaatar M; Jung J
    BMC Public Health; 2022 Nov; 22(1):2098. PubMed ID: 36384532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Possible Impact of Nationwide Vaccination on Outcomes of the COVID-19 Epidemic in North Korea: A Modelling Study.
    Jung SM; Jung J
    J Korean Med Sci; 2022 Oct; 37(41):e300. PubMed ID: 36281488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to COVID-19 during the Tokyo Olympic Games: Did we properly assess the risk?
    Jung SM; Hayashi K; Kayano T; Nishiura H
    Epidemics; 2022 Sep; 40():100618. PubMed ID: 35908478
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.